Marta Caporale

815 total citations
16 papers, 427 citations indexed

About

Marta Caporale is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Marta Caporale has authored 16 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Marta Caporale's work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Genomics and Diagnostics (4 papers). Marta Caporale is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Genomics and Diagnostics (4 papers). Marta Caporale collaborates with scholars based in Italy, Malaysia and Netherlands. Marta Caporale's co-authors include Filippo Pietrantonio, Rosa Berenato, Filippo de Braud, Maria Di Bartolomeo, Alessia Mennitto, Federica Perrone, Massimo Milione, Vincenzo Mazzaferro, Alessandra Alessi and P Dallera and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and European Journal of Cancer.

In The Last Decade

Marta Caporale

16 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Caporale Italy 11 253 150 119 114 96 16 427
Shinichi Asaka Japan 12 161 0.6× 111 0.7× 109 0.9× 175 1.5× 99 1.0× 58 462
Annelies Schnider Switzerland 7 182 0.7× 189 1.3× 221 1.9× 60 0.5× 65 0.7× 14 408
Mahsa Ahadi Australia 10 238 0.9× 176 1.2× 107 0.9× 99 0.9× 106 1.1× 26 445
Erkki‐Ville Wirta Finland 10 303 1.2× 87 0.6× 91 0.8× 51 0.4× 86 0.9× 27 402
Teruyuki SAKAGUCHI Japan 7 344 1.4× 329 2.2× 197 1.7× 200 1.8× 94 1.0× 13 651
Öznur Bal Türkiye 12 175 0.7× 142 0.9× 60 0.5× 78 0.7× 76 0.8× 49 380
U. Torresi Italy 7 315 1.2× 114 0.8× 164 1.4× 102 0.9× 143 1.5× 19 460
Masakatsu Kinuta Japan 10 115 0.5× 252 1.7× 207 1.7× 76 0.7× 20 0.2× 63 473
E. Leo Italy 7 169 0.7× 68 0.5× 153 1.3× 146 1.3× 63 0.7× 15 425
Alper Can Türkiye 12 228 0.9× 146 1.0× 53 0.4× 37 0.3× 20 0.2× 29 338

Countries citing papers authored by Marta Caporale

Since Specialization
Citations

This map shows the geographic impact of Marta Caporale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Caporale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Caporale more than expected).

Fields of papers citing papers by Marta Caporale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Caporale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Caporale. The network helps show where Marta Caporale may publish in the future.

Co-authorship network of co-authors of Marta Caporale

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Caporale. A scholar is included among the top collaborators of Marta Caporale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Caporale. Marta Caporale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Petrelli, Fausto, Rosa Berenato, Luca Turati, et al.. (2017). Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis. Journal of Gastrointestinal Oncology. 8(1). 148–163. 86 indexed citations
2.
Berenato, Rosa, Federica Morano, Filippo Pietrantonio, et al.. (2017). Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions. Oncology. 93(5). 279–286. 8 indexed citations
3.
Salvatore, Mariantonietta Di, Filippo Pietrantonio, Armando Orlandi, et al.. (2017). IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients. Oncotarget. 8(10). 16887–16898. 26 indexed citations
4.
Pietrantonio, Filippo, Daniele Oddo, Annunziata Gloghini, et al.. (2016). MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF -Mutated Colorectal Cancer. Cancer Discovery. 6(9). 963–971. 78 indexed citations
5.
Sartore‐Bianchi, Andrea, Filippo Pietrantonio, Alessio Amatu, et al.. (2016). Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients. European Journal of Cancer. 71. 43–50. 19 indexed citations
6.
Giampieri, Riccardo, Marta Caporale, Filippo Pietrantonio, et al.. (2016). Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded?. Critical Reviews in Oncology/Hematology. 100. 99–106. 9 indexed citations
7.
Pietrantonio, Filippo, Rosa Berenato, Claudia Maggi, et al.. (2016). GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study. Journal of Translational Medicine. 14(1). 125–125. 37 indexed citations
8.
Pietrantonio, Filippo, Maria Di Bartolomeo, Christian Cotsoglou, et al.. (2016). Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases. Clinical Colorectal Cancer. 16(3). e191–e198. 11 indexed citations
9.
Baratti, Dario, Shigeki Kusamura, Massimo Milione, et al.. (2016). Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study. Annals of Surgical Oncology. 23(13). 4222–4230. 23 indexed citations
10.
11.
Moretto, Roberto, Chiara Cremolini, Daniele Rossini, et al.. (2016). Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. The Oncologist. 21(8). 988–994. 79 indexed citations
12.
Pietrantonio, Filippo, Marta Caporale, Rosa Berenato, et al.. (2016). First-line FOLFOX-4 plus panitumumab followed by 5-FU/LV plus panitumumab or single-agent panitumumab as maintenance therapy in patients (pts) with RAS wild-type, metastatic colorectal cancer (mCRC): The VALENTINO study.. Journal of Clinical Oncology. 34(15_suppl). TPS3634–TPS3634. 1 indexed citations
13.
Grassadonia, Antonino, Marta Caporale, Nicola Tinari, et al.. (2015). Effect of Targeted Agents on the Endocrine Response of Breast Cancer in the Neoadjuvant Setting: A Systematic Review. Journal of Cancer. 6(6). 575–582. 4 indexed citations
14.
Orlandi, Armando, Maria Alessandra Calegari, Alessandro Inno, et al.. (2015). BRAF in Metastatic Colorectal Cancer: The Future Starts Now. Pharmacogenomics. 16(18). 2069–2081. 15 indexed citations
15.
Pietrantonio, Filippo, Filippo de Braud, Massimo Milione, et al.. (2015). Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer. Targeted Oncology. 11(3). 337–343. 16 indexed citations
16.
Falvella, Felicia Stefania, Marta Caporale, Stefania Cheli, et al.. (2015). Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase. International Journal of Molecular Sciences. 16(4). 8884–8895. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinichi Asaka Breakdown of academic impact, for papers by Annelies Schnider Breakdown of academic impact, for papers by Mahsa Ahadi Breakdown of academic impact, for papers by Erkki‐Ville Wirta Breakdown of academic impact, for papers by Teruyuki SAKAGUCHI Breakdown of academic impact, for papers by Öznur Bal Breakdown of academic impact, for papers by U. Torresi Breakdown of academic impact, for papers by Masakatsu Kinuta Breakdown of academic impact, for papers by E. Leo Breakdown of academic impact, for papers by Alper Can
Rankless by CCL
2026